Clinical Trial Update: A Study of Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate AD [Phase 4]

View source ↗

Summary

Phase 4 trial update for crisaborole ointment 2% versus vehicle and topical corticosteroids/immune modulators in mild-moderate atopic dermatitis; study terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Crisaborole Ointment (2%) (crisaborole)
• crisaborole vehicle
• topical corticosteroids and topical calcineurin inhibitors

Snippet

Sponsor: Pfizer | Conditions: Atopic Dermatitis | Phase 4 | Status: TERMINATED | Results posted: 2022-01-10